Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Low dose cytarabine monotherapy for acute myeloid leukaemia

Esta versión no es la más reciente

ver la versión actual 03 febrero 2016

Información

DOI:
https://doi.org/10.1002/14651858.CD009480Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 07 diciembre 2011see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Hematología

Copyright:
  1. Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Kathrin Bauer

    Correspondencia a: Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

    [email protected]

  • Franz Hutzschenreuter

    Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

  • Ina Monsef

    Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

  • Nicole Skoetz

    Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

  • Karl‐Anton Kreuzer

    Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

  • Andreas Engert

    Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Contributions of authors

Kathrin Bauer: provided methodological expertise, drafting of protocol, proof read and commented on the first and final draft.

Franz Hutzschenreuter: developed and wrote the first and final draft of the protocol.

Nicole Skoetz: provided methodological expertise, proof read and commented on the first and final draft.

Ina Monsef: developed the search strategies and ran the database searches, provided reference databases.

Karl‐Anton Kreuzer: provided clinical expertise, proof read and commented on the final draft.

Andreas Engert: provided clinical expertise, proof read and commented on the first and final draft.

All authors have read and accepted the final version of the protocol.

Sources of support

Internal sources

  • Salary, Not specified.

    All authors receive salary from the University Hospital of Cologne

External sources

  • No sources of support supplied

Declarations of interest

None known

Acknowledgements

We are grateful to Sabine Kluge and Bettina Schmidtke (Editorial base), Pia Raanani and Sue Richards (Editors) as well as to Céline Fournier (Consumer Editor) for improving the protocol with their valuable comments.

Version history

Published

Title

Stage

Authors

Version

2016 Feb 03

Low dose cytarabine monotherapy for acute myeloid leukaemia

Protocol

Kathrin Bauer, Franz Hutzschenreuter, Ina Monsef, Nicole Skoetz, Karl‐Anton Kreuzer, Andreas Engert

https://doi.org/10.1002/14651858.CD009480.pub2

2011 Dec 07

Low dose cytarabine monotherapy for acute myeloid leukaemia

Protocol

Kathrin Bauer, Franz Hutzschenreuter, Ina Monsef, Nicole Skoetz, Karl‐Anton Kreuzer, Andreas Engert

https://doi.org/10.1002/14651858.CD009480